MAS
62
-2
LLY
60
9
HP
22
-4
ZION
65
-4
ICE
64
-2
BRK.B
33
-3
GM
82
2
SLG
56
-3
EMR
53
-3
UNM
62
-3
CMA
61
-3
HBI
73
2
RHI
30
-3
EMN
55
2
MTCH
50
-10
DAL
69
-4
ADBE
61
-3
CAT
51
-2
WBA
41
-2
TSCO
55
-4
MAS
62
-2
LLY
60
9
HP
22
-4
ZION
65
-4
ICE
64
-2
BRK.B
33
-3
GM
82
2
SLG
56
-3
EMR
53
-3
UNM
62
-3
CMA
61
-3
HBI
73
2
RHI
30
-3
EMN
55
2
MTCH
50
-10
DAL
69
-4
ADBE
61
-3
CAT
51
-2
WBA
41
-2
TSCO
55
-4
Financhill
Back

Cassava Sciences 10K Form

Buy
57

SAVA
Cassava Sciences

Last Price:
$2.11
Seasonality Move:
-0.93%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2020-08-12 10Q SAVA/Cassava Sciences Quarterly
2020-05-06 10Q SAVA/Cassava Sciences Quarterly
2020-03-26 10K SAVA/Cassava Sciences Annual
2019-10-29 10Q SAVA/Cassava Sciences Quarterly
2019-08-12 10Q SAVA/Cassava Sciences Quarterly
2019-05-02 10Q SAVA/Cassava Sciences Quarterly

Receive SAVA News And Ratings

See the #1 stock for the next 7 days that we like better than SAVA

SAVA Financial Statistics

Sales & Book Value

Annual Sales: $41.1M
Cash Flow: $-11.3M
Price / Cash Flow: 0
Annual Sales: $2.64
Price / Book: 0.85

Profitability

EPS (TTM): -1.50000
Net Income (TTM): $-72.8M
Gross Margin: $20.6M
Return on Equity: 0%
Return on Assets: 0%

Cassava Sciences Earnings Forecast

Key Cassava Sciences Financial Ratios

  • The Gross Profit Margin over the past 11 years for SAVA is 100.00%.
  • The Selling, General & Administrative Expenses for SAVA have been equal to 11.76% of Gross Profit Margin.
  • Per Share Earnings over the last 26 years have been positive in 11 years.

Cassava Sciences Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: SAVA
CUSIP: 14817C
Website: cassavasciences.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

SAVA Technical Analysis vs Fundamental Analysis

Buy
57
Cassava Sciences (SAVA) is a Buy

Is Cassava Sciences a Buy or a Sell?

  • Cassava Sciences stock is rated a Buy
    The current Cassava Sciences [SAVA] share price is $2.24. The Score for SAVA is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.